USPTO serial 79109519
VIVA|SCREEN
Reviewed by CopyMark Law Group
Reg. 4277773Status 404
- Filing date
- Status date
- Registration date
- Jan 22, 2013
- Examiner
- WIENER, MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VIVA|SCREEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
BREWSTER TAYLOR
BREWSTER TAYLOR STITES & HARBISON PLLC1800 DIAGONAL ROADSUITE 325ALEXANDRIA, VA 22314Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Molecules obtained from biotechnologies, namely, proteins in raw material form for industrial use, scientific or medical research; biotechnological products for research and diagnosis, namely, chemicals, antibodies, antigens; micro-organisms, namely, cultures of microorganisms other than for medical and veterinary use; cells for scientific and laboratory uses; pre made and biological cell lines for scientific and laboratory uses; viruses for scientific and laboratory uses; nucleotides for use as biochemical reagents; plasmids for use as biochemical reagents; DNA or RNA sequences for use as biochemical reagents; antibodies for scientific and industrial research; cells for cloning for the production of antibodies; vectors for research and diagnosis; all of the previous products being not for medical or veterinary purposes; biological preparations for use in cell cultures other than for medical or veterinary purposes; bacteriological preparations for use in cell cultures other than for medical and veterinary use | SECTION 71 - CANCELLED | — |
| 005 | Prophylactic and therapeutic medicines and pharmaceutical products for the prevention, diagnosis and cure of diseases that induce an immune response; Prophylactic and therapeutic veterinary products for the prevention, diagnosis and cure of diseases that induce an immune response; biological, biotechnological preparations and products obtained via genetic technology for medical or pharmaceutical purposes in the nature of preventing, diagnosing and curing diseases that induce an immune response; biological, biotechnological preparations and products obtained via genetic technology for veterinary purposes in the nature of preventing, diagnosing and curing diseases that induce an immune response; micro-organisms; cells; cell lines; viruses; nucleotides; plasmids; DNA or RNA sequences; antibodies; cell clones producing antibodies; vectors for therapy and diagnostic for medical purposes; molecules and antibodies, all for medical and pharmaceutical purposes in the nature of cell cultures, biochemical reagents, reagents for sample preparation, reagents for targeting and recovering targeted cells; biotechnological products for medical and pharmaceutical purposes in the nature of cell cultures, biochemical reagents, reagents for sample preparation, reagents for targeting and recovering targeted cells; products for diagnosis for medical and pharmaceutical purposes, namely, proteins, antibodies, and products comprising these molecules for the diagnosis of diseases that induce an immune response; prophylactic or therapeutic vaccines | SECTION 71 - CANCELLED | — |
| 009 | Scientific apparatus and instruments, namely, typical equipment used in laboratories to take blood samples, to harvest biological cells, to select targeted cells, and microarrays chips for the identification and/or isolation of antibodies or the separation and recovery of cell clones producing antibodies in biological samples | SECTION 71 - CANCELLED | — |
| 042 | Scientific services, namely, research and development of new products or process for production and/or purification of biological products for third parties; biological research; bacteriological, virology, immunology, biotechnology, genetic, medicine and pharmacology research; scientific research services for medical purposes; scientific research services for pharmaceutical purposes; scientific research services for veterinary purposes; development of new technologies for others in the field of biotechnology, biological and medical research; development of scientific and industrial research means inter alia to identify and isolate antibodies or cell clones producing antibodies | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by VALNEVA
- Other trademarks owned by VIVALIS
- Other trademarks owned by VIVALIS
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named VIVA|SCREEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 5, 2022 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jun 5, 2022 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 10, 2020 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 8, 2020 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 8, 2020 | INPC | INVALIDATION PROCESSED | — |
| Apr 23, 2020 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 26, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 23, 2019 | C71T | CANCELLED SECTION 71 | — |
| Jan 22, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 15, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 28, 2014 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 14, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 25, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 25, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 22, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 2, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 22, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 15, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 6, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 17, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 17, 2012 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 17, 2012 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 28, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 21, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 21, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2012 | ALIE | ASSIGNED TO LIE | — |
| Sep 19, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 14, 2012 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 5, 2012 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 27, 2012 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 14, 2012 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 22, 2012 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 22, 2012 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 22, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 21, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 14, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 14, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 13, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |